The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Celgene Corp.

  • CELG
  • NASDAQ
  • Consumer Products
  • Latest 95.09
  • Currency US$
  • Change 0.39
  • Percent Change 0.412 %
  • Volume 963,194
  • Fri Aug 29, 2014 11:40 AM EDT NASDAQ data delayed 15 minutes.
  • Open 95.28
  • Previous Close 94.70
  • High 95.29
  • Low 94.262
  • Bidx5 95.06
  • Askx2 95.10
  • 52-week High08/27 96.15
  • 52-week Low04/15 66.85
  • Beta 2.332
  • Market Cap 38,075.94M
  • EPS 1.74
  • P/E 54.649
  • Forward P/E 21.38
  • PEG 1.13
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $6,759,300,000
  • Earnings $1,344,700,000
  • Return on Equity 26.70%

Cash Flow

  • Cash Flow --
  • Cash $2,396,600,000
  • Current Ratio 2.86

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $12,704,500,000
  • Liabilities $8,219,900,000
  • Liabilities-to-Equity Ratio 1.83

Price Ratios

  • Price to Sales 5.63
  • Price to Book 8.49
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jul 24 $0.77 Oct 23 $0.82
Surprises Jul 24 3.90% n/a n/a
Dividends n/a n/a n/a n/a
Splits Jun 26 2:1 n/a n/a

12 months ended Aug 29, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

Related Securities
Symbol Type Latest % Chg

Officers

  • Robert J. Hugin Chairman of the Board & C.E.O.
  • Jacqualyn A. Fouse Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

86 MORRIS AVENUE
SUMMIT, NJ
07901

Phone: (908)-673-9000
Fax: (908)-6739001

ir@celgene.com
www.celgene.com

Ideas & Discussion

Live Discussion of CELG on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.